Literature DB >> 22381812

Predictors during childhood of future health-related quality of life in adults with Gilles de la Tourette syndrome.

Andrea E Cavanna1, Kate David, Michael Orth, Mary M Robertson.   

Abstract

BACKGROUND: Gilles de la Tourette syndrome (GTS) is a chronic neurodevelopmental disorder characterised by multiple motor and phonic tics and behavioural problems. Patients with GTS of all ages often report a poor health-related quality of life (HR-QOL). The diagnosis of GTS is usually established in childhood but little is known about factors that predict the long-term well-being of patients, especially in the presence of co-morbid behavioural problems. AIM: To investigate the childhood predictors of HR-QOL in a cohort of adult patients with GTS.
METHODS: Forty-six patients with GTS aged 6-16 years underwent a baseline standardised clinical assessment of both tics and behavioural symptoms at a specialist GTS clinic. The same patients were re-assessed aged 16 years and above, with a mean follow-up period of 13 years (range 3-25 years), when they completed the Gilles de la Tourette Syndrome-Quality of Life Scale (GTS-QOL), a disease-specific measure of HR-QOL.
RESULTS: Tic severity, premonitory urges and family history of GTS were identified as predictors during childhood of a poorer HR-QOL in adults with GTS by multiple linear regression analysis. Specifically, tic severity significantly predicted poor outcome across physical, psychological and cognitive domains of the GTS-QOL, reflecting widespread effects on HR-QOL.
CONCLUSION: Young patients with severe tics associated with characteristic premonitory urges and a family history of tic disorders appear to be at higher risk for poorer HR-QOL as adults. Further prospective research into HR-QOL in GTS is required in order to inform long-term strategic resource allocation.
Copyright © 2012 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22381812     DOI: 10.1016/j.ejpn.2012.02.004

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  16 in total

1.  Bridging neuroscience and clinical psychology: cognitive behavioral and psychophysiological models in the evaluation and treatment of Gilles de la Tourette syndrome.

Authors:  Marc E Lavoie; Julie Leclerc; Kieron P O'Connor
Journal:  Neuropsychiatry (London)       Date:  2013-02-01

2.  Tic-related activity restriction as a predictor of emotional functioning and quality of life.

Authors:  Christine A Conelea; Andrew M Busch; Mark A Catanzaro; Cathy L Budman
Journal:  Compr Psychiatry       Date:  2013-10-22       Impact factor: 3.735

3.  Tic Suppression in Children With Recent-Onset Tics Predicts 1-Year Tic Outcome.

Authors:  Soyoung Kim; Deanna J Greene; Amy Robichaux-Viehoever; Emily C Bihun; Jonathan M Koller; Haley Acevedo; Bradley L Schlaggar; Kevin J Black
Journal:  J Child Neurol       Date:  2019-06-26       Impact factor: 1.987

Review 4.  The role of atypical antipsychotics for treatment of Tourette's syndrome: an overview.

Authors:  Cathy L Budman
Journal:  Drugs       Date:  2014-07       Impact factor: 9.546

5.  Long-Term Follow-up of Patients with Tourette's Syndrome.

Authors:  Thomas L Lowe; Matthew R Capriotti; Keith McBurnett
Journal:  Mov Disord Clin Pract       Date:  2018-11-16

Review 6.  Neurobiology of the Premonitory Urge in Tourette's Syndrome: Pathophysiology and Treatment Implications.

Authors:  Andrea E Cavanna; Kevin J Black; Mark Hallett; Valerie Voon
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2017-01-25       Impact factor: 2.198

7.  Tourette syndrome and consciousness of action.

Authors:  Andrea E Cavanna; Andrea Nani
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2013-09-23

8.  Comorbidities, Social Impact, and Quality of Life in Tourette Syndrome.

Authors:  Valsamma Eapen; Andrea E Cavanna; Mary M Robertson
Journal:  Front Psychiatry       Date:  2016-06-06       Impact factor: 4.157

Review 9.  The effects of Gilles de la Tourette syndrome and other chronic tic disorders on quality of life across the lifespan: a systematic review.

Authors:  Joel Evans; Stefano Seri; Andrea E Cavanna
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-02-15       Impact factor: 4.785

Review 10.  Safety and efficacy of aripiprazole for the treatment of pediatric Tourette syndrome and other chronic tic disorders.

Authors:  Joanna H Cox; Stefano Seri; Andrea E Cavanna
Journal:  Pediatric Health Med Ther       Date:  2016-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.